{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:29:24Z","timestamp":1740144564653,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary Focal Hyperhidrosis (PFH) has a detrimental effect on Quality of Life. Repetitive, non-curative symptomatic strategies dominate current treatment of PFH, in spite of the availability of an effective and permanent curative treatment like Endoscopic Thoracic Sympathectomy (ETS). Current surgical optimization may allow for a re-established position of sympathetic modulation in this treatment algorithm. We sought to evaluate the safety, effectiveness, and long-term results of a Bilateral One-stage Single-port Sympathicotomy (BOSS) procedure in PFH patients and to identify subgroups benefitting most.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Prospective analysis of 163 patients, 35 (21.5%) underwent Rib-3 (R3) BOSS for palmar PFH, 58 (35.6%) R3-R5 BOSS for axillary PFH and 70 (42.9%) R3-R5 BOSS for combined palmar\/axillary PFH. Effectiveness was measured using Skindex-29 and the Hyperhidrosis Disease Severity Scale (HDSS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall Skindex-29-rating (46.5\u2009\u00b1\u200914.8 preoperatively vs 20.1\u2009\u00b1\u200920.6 postoperatively, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and HDSS score (3.71\u2009\u00b1\u20090.45 preoperatively vs 1.82\u2009\u00b1\u20090.86 postoperatively, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) indicated a significant improvement in health-related quality of life after BOSS. R3 BOSS was superior to R3-R5 BOSS in terms of HDSS score (1.49 vs 1.91 respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) and in terms of severe compensatory hyperhidrosis, a frequently reported side-effect (17.1% vs 32.8% respectively, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). No major complications occurred.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BOSS is safe, effective, and offers a long-term curative solution in the treatment of PFH. Especially in the palmar PFH subgroup, R3 BOSS treatment results compare favorably to the treatment results of non-curative alternatives published in the current literature. Therefore, R3 BOSS should be offered to all patients with severe PFH, reporting insufficient benefit of treatment options such as oral and\/or local agents.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-021-01430-0","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T10:02:30Z","timestamp":1616666550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bilateral one-stage single-port sympathicotomy in primary focal hyperhidrosis, a prospective cohort study: treat earlier?"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-8556","authenticated-orcid":false,"given":"Michiel","family":"Kuijpers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra W.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wobbe","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike J.","family":"DeJongste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo A.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo J.","family":"Klinkenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"issue":"1","key":"1430_CR1","first-page":"25","volume":"37","author":"M Amir","year":"2000","unstructured":"Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci. 2000;37(1):25\u201331.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"2","key":"1430_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1430_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s002660010046","volume":"24","author":"A Goldman","year":"2000","unstructured":"Goldman A. Treatment of axillary and palmar hyperhidrosis with botulinum toxin. Aesthet Plast Surg. 2000;24(4):280\u20132. https:\/\/doi.org\/10.1007\/s002660010046.","journal-title":"Aesthet Plast Surg"},{"issue":"3","key":"1430_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjd.16558","volume":"179","author":"R Wade","year":"2018","unstructured":"Wade R, Llewellyn A, Jonesd-Diette J, Wright K, Rice S, Layton AM, et al. Interventional management of hyperhidrosis in secondary care: a systematic review. Br J Dermatol. 2018;179(3):599\u2013608. https:\/\/doi.org\/10.1111\/bjd.16558.","journal-title":"Br J Dermatol"},{"issue":"11","key":"1430_CR5","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00268-008-9716-4","volume":"32","author":"D Kopelman","year":"2008","unstructured":"Kopelman D, Hashmonai M. The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review. World J Surg. 2008;32(11):2343\u201356. https:\/\/doi.org\/10.1007\/s00268-008-9716-4.","journal-title":"World J Surg"},{"issue":"8","key":"1430_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G, Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity- based treatment of focal hyperhidrosis: recommendations of the Canadian hyperhidrosis advisory committee. Dermatol Surg. 2007;33(8):908\u201323. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33192.x.","journal-title":"Dermatol Surg"},{"key":"1430_CR7","first-page":"86","volume":"31","author":"R Leriche","year":"1934","unstructured":"Leriche R, Frieh P. Hyperhidrose Extremement Prononcee des Maines et des Pieds. Lyon Chir. 1934;31:86.","journal-title":"Lyon Chir"},{"issue":"3","key":"1430_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/archsurg.1978.01370150036005","volume":"113","author":"M Kux","year":"1978","unstructured":"Kux M. Thoracic endoscopic sympathectomy in palmar and axillary hyperhidrosis. Arch Surg. 1978;113(3):264\u20136. https:\/\/doi.org\/10.1001\/archsurg.1978.01370150036005.","journal-title":"Arch Surg"},{"issue":"3","key":"1430_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0003-4975(03)00895-6","volume":"76","author":"JR de Campos","year":"2003","unstructured":"de Campos JR, Kauffman P, Werebe Ede C, Andrade Filho LO, Kusniek S, Wolosker N, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886\u201391. https:\/\/doi.org\/10.1016\/S0003-4975(03)00895-6.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"1430_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s100169910070","volume":"14","author":"SS Ahn","year":"2000","unstructured":"Ahn SS, Wieslander CK, Ro KM. Current developments in thoracoscopic sympathectomy. Ann Vasc Surg. 2000;14(4):415\u201320. https:\/\/doi.org\/10.1007\/s100169910070.","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"1430_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejcts.2006.04.016","volume":"30","author":"MO Murphy","year":"2006","unstructured":"Murphy MO, Ghosh J, Khwaja N, Murray D, Halka AT, Carter A, et al. Upper dorsal endoscopic thoracic sympathectomy: a comparison of one- and two-port ablation techniques. Eur J Cardiothorac Surg. 2006;30(2):223\u20137. https:\/\/doi.org\/10.1016\/j.ejcts.2006.04.016.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1430_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1749-8090-8-216","volume":"8","author":"M Kuijpers","year":"2013","unstructured":"Kuijpers M, Klinkenberg TJ, Bouma W, DeJongste MJ, Mariani MA. Single-port one-stage bilateral thoracoscopic sympathicotomy for severe hyperhidrosis: prospective analysis of a standardized approach. J Cardiothorac Surg. 2013;8:216.","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"1430_CR13","first-page":"161","volume":"90","author":"CC Lin","year":"2001","unstructured":"Lin CC, Telaranta T. Lin-Telaranta classification: the importance of different procedures for different indications in sympathetic surgery. Ann Chir Gynaecol. 2001;90(3):161\u20136.","journal-title":"Ann Chir Gynaecol"},{"issue":"1 Suppl","key":"1430_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3171\/spi.2003.99.1.0039","volume":"99","author":"DH Yoon","year":"2003","unstructured":"Yoon DH, Ha Y, Park YG, Chang JW. Thoracoscopic limited T-3 sympathectomy for primary hyperhidrosis: prevention for compensatory hyperhidrosis. J Neurosurg. 2003;99(1 Suppl):39\u201343. https:\/\/doi.org\/10.3171\/spi.2003.99.1.0039.","journal-title":"J Neurosurg"},{"issue":"2","key":"1430_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10286-010-0110-6","volume":"21","author":"F Scognamillo","year":"2011","unstructured":"Scognamillo F, Serventi F, Attene F, Torre C, Paliogiannis P, Pala C, Trignano E, Trignano M. T2-T4 sympathectomy versus T3-T4 sympathicotomy for palmar and axillary hyperhidrosis. Clin Auton Res. 2011;21(2):97\u2013102. https:\/\/doi.org\/10.1007\/s10286-010-0110-6.","journal-title":"Clin Auton Res"},{"issue":"2","key":"1430_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4065\/78.2.167","volume":"78","author":"JL Atkinson","year":"2003","unstructured":"Atkinson JL, Fealey RD. Sympathotomy instead of sympathectomy for palmar hyperhidrosis: minimizing postoperative compensatory hyperhidrosis. Mayo Clin Proc. 2003;78(2):167\u201372. https:\/\/doi.org\/10.4065\/78.2.167.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1430_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LP, Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274\u201386. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.029.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433\u201340. https:\/\/doi.org\/10.1001\/archderm.1997.03890470111018.","journal-title":"Arch Dermatol"},{"issue":"9","key":"1430_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/jid.2011.138","volume":"131","author":"AC Prinsen","year":"2011","unstructured":"Prinsen AC, Lindeboom R, Korte De J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol. 2011;131(9):1945\u20137. https:\/\/doi.org\/10.1038\/jid.2011.138.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1430_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1023\/A:1008968401068","volume":"8","author":"CS Cina","year":"1999","unstructured":"Cina CS, Clase CM. The illness intrusiveness rating scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res. 1999;8(8):693\u20138. https:\/\/doi.org\/10.1023\/A:1008968401068.","journal-title":"Qual Life Res"},{"issue":"1","key":"1430_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13555-016-0148-z","volume":"7","author":"A Grabell","year":"2017","unstructured":"Grabell A, Hebert A. Current and emerging medical therapies for primary hyperhidrosis. Dermatol Ther (Heidelb). 2017;7(1):25\u201336. https:\/\/doi.org\/10.1007\/s13555-016-0148-z.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"1430_CR22","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/bjd.15808","volume":"178","author":"Y Hu","year":"2018","unstructured":"Hu Y, Converse C, Lyons MC, Hsu WH. Neural control of sweat secretion: a review. Br J Dermatol. 2018;178(6):1246\u201356.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1430_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2011.01.023","volume":"66","author":"HW Walling","year":"2012","unstructured":"Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol. 2012;66(3):387\u201392. https:\/\/doi.org\/10.1016\/j.jaad.2011.01.023.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1430_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jaad.2012.02.012","volume":"67","author":"AS Paller","year":"2012","unstructured":"Paller AS, Shah PR, Silverio AM, Wagner A, Chamlin SL, Mancini AJ. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. J Am Acad Dermatol. 2012;67(5):918\u201323. https:\/\/doi.org\/10.1016\/j.jaad.2012.02.012.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1430_CR25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/bjd.13973","volume":"173","author":"M Schollhammer","year":"2015","unstructured":"Schollhammer M, Brenaut E, Menard-Andivot N, Pillette-Delarue M, Zagnoli A, Chassain-Le Lay M, et al. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial. Br J Dermatol. 2015;173(5):1163\u20138. https:\/\/doi.org\/10.1111\/bjd.13973.","journal-title":"Br J Dermatol"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.athoracsur.2006.06.067","volume":"83","author":"R Reisfeld","year":"2007","unstructured":"Reisfeld R. One-year follow-up after thoracoscopic sympathectomy for hyperhidrosis. Ann Thorac Surg. 2007;83:354\u201360.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"1430_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1590\/S1807-59322009000800006","volume":"64","author":"G Yazbek","year":"2009","unstructured":"Yazbek G, Wolosker N, Kaufmann P, de Campos JR, Puech-Le\u00e3o P, Jatene FB. Twenty months of evolution following sympathectomy on patients with palmar hyperhidrosis: sympathectomy at the t3 level is better than at the t2 level. Clinics. 2009;64(8):743\u20139. https:\/\/doi.org\/10.1590\/S1807-59322009000800006.","journal-title":"Clinics"},{"issue":"1","key":"1430_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41598-017-00169-w","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang W, Yu D, Wei Y, Xu J, Zhang X. A systematic review and meta-analysis of T2, T3 or T4, to evaluate the best denervation level for palmar hyperhidrosis. Sci Rep. 2017;7(1):129. https:\/\/doi.org\/10.1038\/s41598-017-00169-w.","journal-title":"Sci Rep"},{"issue":"3","key":"1430_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1590\/S1806-37132007000300004","volume":"33","author":"J Montessi","year":"2007","unstructured":"Montessi J, Almeida EP, Vieira JP, Abreu Mda M, Souza RL, Montessi OV. Video-assisted thoracic sympathectomy in the treatment of primary hyperhidrosis: a retrospective study of 521 cases comparing different levels of ablation. J Bras Pneumol. 2007;33(3):248\u201354. https:\/\/doi.org\/10.1590\/S1806-37132007000300004.","journal-title":"J Bras Pneumol"},{"issue":"11","key":"1430_CR30","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1007\/s00464-017-5508-y","volume":"31","author":"HW Sang","year":"2017","unstructured":"Sang HW, Li G, Xiong P, Zhu MG, Zhu M. Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review. Surg Endosc. 2017;31(11):4357\u201369. https:\/\/doi.org\/10.1007\/s00464-017-5508-y.","journal-title":"Surg Endosc"},{"issue":"4","key":"1430_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.athoracsur.2018.05.023","volume":"106","author":"EF Salim","year":"2018","unstructured":"Salim EF, Ali GA. Impact of thoracoscopic T2 sympathectomy on patients with primary palmar and axillary hyperhidrosis. Ann Thorac Surg. 2018;106(4):1032\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.05.023.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1430_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jvs.2011.12.039","volume":"55","author":"N Wolosker","year":"2012","unstructured":"Wolosker N, de Campos JRM, Kauffman P, Puech-Le\u00e3o P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012;55(6):1696\u2013700. https:\/\/doi.org\/10.1016\/j.jvs.2011.12.039.","journal-title":"J Vasc Surg"},{"issue":"3","key":"1430_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mjafi.2014.01.008","volume":"70","author":"R Rajagopal","year":"2014","unstructured":"Rajagopal R, Mallya NB. Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminium chloride hexahydrate in treatment of palmar hyperhidrosis. Med J Armed Forces India. 2014;70(3):247\u201352. https:\/\/doi.org\/10.1016\/j.mjafi.2014.01.008.","journal-title":"Med J Armed Forces India"},{"issue":"11","key":"1430_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/ijd.12625","volume":"53","author":"A Kouris","year":"2014","unstructured":"Kouris A, Agiasofitou E, Gregoriou S, Sofouri E, Kontochrisopoulos G, Panagopoulos G. Generalized neurological symptoms following treatment of focal hyperhidrosis with botulinumtoxin a. Int J Dermatol. 2014;53(11):544\u20137.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1430_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.athoracsur.2009.04.003","volume":"88","author":"V Ambrogi","year":"2009","unstructured":"Ambrogi V, Campione E, Mineo D, Patern\u00f2 EJ, Ponpeo E, Mineo TC. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis. Ann Thorac Surg. 2009;88(1):238\u201345. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.04.003.","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-021-01430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-021-01430-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-021-01430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T10:10:23Z","timestamp":1616667023000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-021-01430-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1186\/s13019-021-01430-0","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"12 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee. This study was conducted with the formal and written approval of the Dutch Medical Ethics Comity (METc UMCG 2015\/104). It is compatible with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants gave written consent to inclusion and are fully anonymized. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained for Fig.\u00a0.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}